Source:http://linkedlifedata.com/resource/pubmed/id/10527633
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1999-12-7
|
pubmed:abstractText |
We analyzed the formation of homo- and heterodimers between EGFR, ErbB2, and ErbB3 (members of the EGF receptor family) in the human skin keratinocyte cell line HaCaT, in dependence of the added ligand. ErbB4 was not unambiguously identified. By immunoprecipitation and Western blots, we showed the formation of heterodimers between all members of the family. Whereas EGF and TGF-alpha strongly induced heterodimerization, no effect was observed with heregulin. At the concentrations used all ligands elicited a similar, differentiation-independent activation of erk1/2 MAP kinase, with the exception of heregulin which activated p42/44 only marginally. We also found that different ligands triggered different transcription patterns of "early genes," with the exception of heregulin which did not modulate transcription. TGF-alpha was the most efficient ligand in promoting incorporation of tritiated thymidine into the DNA.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0014-4827
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 1999 Academic Press.
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
252
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
432-8
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:10527633-Cell Line,
pubmed-meshheading:10527633-Humans,
pubmed-meshheading:10527633-Keratinocytes,
pubmed-meshheading:10527633-Receptor, Epidermal Growth Factor,
pubmed-meshheading:10527633-Receptor, erbB-2,
pubmed-meshheading:10527633-Receptor, erbB-3,
pubmed-meshheading:10527633-Signal Transduction
|
pubmed:year |
1999
|
pubmed:articleTitle |
EGFR family-mediated signal transduction in the human keratinocyte cell line HaCaT.
|
pubmed:affiliation |
Deutsches Krebsforschungszentrum, Im Neuenheimer Feld-242, Heidelberg, 69120, Germany.
|
pubmed:publicationType |
Journal Article
|